Objective This epidemiologic study was undertaken after a cluster of f
ive cases of rare forms of cancer (bone sarcoma, non-Hodgkin's lymphom
a) had been observed among biomedical research workers at the Pasteur
Institute in Paris to ascertain whether their disease was connected wi
th exposure during this research. Methods A mortality study included 3
765 people who worked at the Pasteur Institute between 1971 and 1986 a
nd were followed until the end of 1987. Within this cohort a nested ca
se-referent study included 23 cases of cancer [non-Hodgkin's lymphoma
(6), multiple myeloma (1), leukemia (3), pancreatic cancer (7), bone c
ancer (3), brain tumor (3)], and four referents per case, matched for
gender and year of birth. Results Total mortality from cancer was less
than expected, the standardized mortality ratio (SMR) being 72 for th
e men and 82 for the women. Among the women the proportion of pancreat
ic cancer cases was larger than expected [SMR 490, 95% confidence inte
rval (95% CI) 158-1144], as was the number of brain cancer cases (SMR
239, 95% CI 48-696). Among the men, mortality from bone cancer was gre
ater than expected (SMR 553, 95% CI 62-2006). In the nested case-refer
ent study, more cases than referents had worked in the areas of molecu
lar biology [odds ratio (OR) 7.1, 95% CI 1.5-33] and microbial genetic
s (OR 6.7, 95% CI 1.3-35). These cases especially included non-Hodgkin
's lymphoma and bone cancer. Associated with this finding was the fact
that more cases had used certain chemicals, including ethidium bromid
e, acrylamide, methylnitro-nitrosoguanidine and ethylmethanesulfonate,
and radioactive compounds (essentially (32)phosphorus). Conclusions A
s the products used are potent genotoxicants, the present findings sug
gest that work in biomedical research might well involve an increased
risk of certain types of cancer; this conclusion should be balanced by
the fact that two of the five index cases were included in the mortal
ity study and four in the nested case-referent study.